格隆汇7月8日丨TATA健康(01255.HK)公告，自2025年6月23日起：(i)张鸣琪已获委任为非执行董事；(ii)陈琦已获委任为非执行董事；(iii)黄琳已获委任为公司独立非执行董事及审核委员会、提名委员会及薪酬委员会成员；(iv)李亮已获委任为公司独立非执行董事及审核委员会、提名委员会及薪酬委员会成员；(v)杜建峰已获委任为公司独立非执行董事及审核委员会、提名委员会及薪酬委员会成员。
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.